Omnicell Signs Agreement with Bupa Care Homes to Acquire UK-Based SurgiChem Limited; Terms Undisclosed

Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of medication and supply management solutions to healthcare systems, today announced that it has signed an agreement with Bupa Care Homes (CFG) plc to purchase the entire outstanding share capital of SurgiChem Limited, a wholly-owned subsidiary of Bupa, for £12,000,000 subject